Sign in

CIK 0000730272 · Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
042729386
Phone
7814499560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. SC 13D/A Stake Beneficial Ownership Report
  2. SC 13D/A Stake Beneficial Ownership Report
  3. SC 13D/A Stake Beneficial Ownership Report
  4. 10-Q Report Quarterly Report
  5. SC 13D/A Stake Beneficial Ownership Report
  6. SC 13D/A Stake Beneficial Ownership Report
  7. SC 13D Stake Beneficial Ownership Report
  8. 10-Q Report Quarterly Report
  9. 10-Q Report Quarterly Report
  10. DEF 14A Proxy Proxy Statement
  11. 10-K Report Annual Report
  12. 10-Q Report Quarterly Report
  13. NT 10-Q Other NT 10-Q
  14. 10-Q Report Quarterly Report
  15. DEF 14A Proxy Proxy Statement
  16. 10-K/A Report 10-K/A
  17. 10-Q Report Quarterly Report
  18. 10-K Report Annual Report
  19. NT 10-K Other NT 10-K

Page 69 of 69 · 1,379 filings